The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COSTEM 2019 | Preventing relapse post-transplant in AML and MDS?
Marcos de Lima, MD, University Hospitals Cleveland Medical Center, Cleveland, OH, outlines the current guidelines in preventing relapse in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.
